Company Overview

At ZOLL, we’re passionate about improving patient outcomes and helping save lives.

We provide innovative technologies that make a meaningful difference in people's lives. Our medical devices, software, and related services are used worldwide to diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions.

Founded in 1980, ZOLL is named after Dr. Paul Zoll, whose pioneering work in cardiology and resuscitation earned him the nickname “The Father of Modern Electrophysiology.”

Today, ZOLL is a global leader in acute critical care and related software and diagnostic tools.

How we help

Every day, people face serious health conditions and life-threatening emergencies. ZOLL solutions aid in the diagnosis, treatment, real-time response, and operational processes needed to make better outcomes possible. We provide a comprehensive portfolio of medical devices and software solutions that:

  • Improve outcomes for patients with serious cardiopulmonary and respiratory conditions
  • Help advance emergency care and save lives
  • Increase clinical and operational efficiencies

ZOLL partners with healthcare professionals and lay rescuers to address a variety of serious conditions, with solutions for:

  • Defibrillation and cardiac monitoring
  • Circulation enhancement and CPR feedback
  • Supersaturated oxygen therapy
  • Ventilation
  • Therapeutic temperature management
  • Sleep apnea diagnosis and treatment
  • Data management

About ZOLL

ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit

About Asahi Kasei

The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 46,000 employees around the world, the company contributes to a sustainable society by providing solutions to the world's challenges through its three business sectors of Material, Homes, and Health Care. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. For more information, visit

Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit